|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Provision for credit losses | |||||
| Net accretion of discounts and amortization of premium on securities and borrowings | |||||
| Amortization of other intangible assets | |||||
| Losses (gains) on securities transactions, net | |||||
| (Gains) losses on available for sale and held to maturity debt securities, net | |||||
| Proceeds from sales of loans held for sale at fair value | |||||
| (Gains) losses on sales of loans, net | |||||
| Originations of loans held for sale | |||||
| Losses (gains) on sales of assets, net | |||||
| Loss on extinguishment of debt | |||||
| Net deferred income tax expense (benefit) | |||||
| Net change in: | |||||
| Fair value of financial instruments hedged by derivative transactions | |||||
| Trading debt securities | |||||
| Lease right of use assets | |||||
| Cash surrender value of bank owned life insurance | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Loans originated and purchased, net of principal collected | |||||
| Equity securities: | |||||
| Purchases | |||||
| Sales and capital returns | |||||
| Held to maturity debt securities: | |||||
| Purchases | |||||
| Maturities, calls and principal repayments | |||||
| Available for sale debt securities: | |||||
| Purchases | |||||
| Sales | |||||
| Maturities, calls and principal repayments | |||||
| Death benefit proceeds from bank owned life insurance | |||||
| Proceeds from sales of real estate property and equipment | |||||
| Proceeds from sales of loans not originated for sale | |||||
| Proceeds from sale of commercial premium finance lending division | |||||
| Purchases of real estate property and equipment | |||||
| Cash and cash equivalents acquired in acquisitions, net | |||||
| Common stock issued in acquisition | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in deposits | |||||
| Net change in short-term borrowings | |||||
| Proceeds from issuance of long-term borrowings, net | |||||
| Repayments of long-term borrowings | |||||
| Proceeds from issuance of preferred stock, net | |||||
| Cash dividends paid to preferred shareholders | |||||
| Cash dividends paid to common shareholders | |||||
| Purchase of common shares related to stock compensation plan activity | |||||
| Purchase of common shares to treasury | |||||
| Common stock issued, net | |||||
| Other, net | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest on deposits and borrowings | |||||
| Federal and state income taxes | |||||
| Supplemental schedule of non-cash investing activities: | |||||
| Transfer of loans to other real estate owned, net | |||||
| Transfer of loans to loans held for sale, net | |||||
| Lease right of use assets obtained in exchange for operating lease liabilities | |||||
| Equity securities | |||||
| Investment securities available for sale | |||||
| Investment securities held to maturity | |||||
| Loans, net | |||||
| Premises and equipment | |||||
| Lease right of use assets | |||||
| Bank owned life insurance | |||||
| Accrued interest receivable | |||||
| Goodwill | |||||
| Other intangible assets | |||||
| Other assets | |||||
| Total non-cash assets acquired | |||||
| Deposits | |||||
| Short-term borrowings | |||||
| Lease liabilities | |||||
| Accrued expenses and other liabilities | |||||
| Total liabilities assumed | |||||
| Net non-cash assets acquired | |||||
Loading...